BIOMAT Database Logo BIOMAT Database Logo

[A case of salvage treatment for local recurrence of squamous cell anal carcinoma after chemoradiation]. 2010

Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Dept. of Surgery, National Hospital Organization, Osaka National Hospital.

A 76-year-old woman consulted her local physician because she experienced anal pain during defecation. She was diagnosed with squamous cell anal carcinoma and underwent chemoradiation (59.4 Gy + UFT 500 mg/5 days/week). The examinations after chemoradiation revealed a complete remission of the tumor. She was followed up and 8 months later, she experienced anal erosion and pain. Local recurrence was observed, however, distant metastasis was not observed. Abdominoperineal resection (APR) was performed as salvage treatment, and she has been disease free for 10 months. Functional preservation employing concomitant chemoradiation has become the standard treatment for most case of squamous cell anal carcinoma, with APR backup being a salvage procedure. However, approximately 30% of the cases require a salvage operation because of primary non-response or recurrence. We predict that the incidence of such cases will increase in the future.

UI MeSH Term Description Entries
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D001005 Anus Neoplasms Tumors or cancer of the ANAL CANAL. Anal Cancer,Cancer of Anus,Anal Neoplasms,Cancer of the Anus,Neoplasms, Anal,Neoplasms, Anus,Anal Cancers,Anal Neoplasm,Anus Cancer,Anus Cancers,Anus Neoplasm,Cancer, Anal,Cancers, Anal,Neoplasm, Anal,Neoplasm, Anus
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Chemoradiation for anal squamous cell carcinoma: case report.
January 2011, Il Giornale di chirurgia,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation.
April 2024, Journal of clinical medicine,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy.
December 2014, Hepatology research : the official journal of the Japan Society of Hepatology,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Chemoradiation therapy for squamous cell carcinoma of anal canal cancer: report of a case.
January 2000, Radiation medicine,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
September 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
September 2019, Radiation oncology (London, England),
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Outcome of salvage surgery for anal squamous cell carcinoma.
August 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Predictors of recurrence following local excision for early-stage anal squamous cell carcinoma.
November 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
Salvage treatment for superficial local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
January 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society,
Hironobu Goto, and Masakazu Ikenaga, and Masayoshi Yasui, and Michihiko Miyazaki, and Hideyuki Mishima, and Masanori Tsujie, and Atsushi Miyamoto, and Motohiro Hirao, and Kazumasa Fujitani, and Shoji Nakamori, and Ken Yoshida, and Toshimasa Tsujinaka
DPD testing in radical chemoradiation for anal squamous cell carcinoma.
November 2020, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!